S1401 |
Tenofovir
|
Tenofovir (GS-1278) blocks reverse transcriptase and hepatitis B virus infections. |
-
J Biomed Sci, 2024, 31(1):34
-
Hepatol Commun, 2024, 8(1)e0351
-
Nat Commun, 2023, 14(1):199
|
|
S1400 |
Tenofovir Disoproxil Fumarate
|
Tenofovir Disoproxil Fumarate belongs to a class of antiretroviral drugs, it inhibits the activity of HIV reverse transcriptase by competing with the natural substrate deoxyadenosine 5’-triphosphate and, after incorporation into DNA, by DNA chain termination. |
-
Clin Immunol, 2024, 260:109915
-
Front Cell Infect Microbiol, 2024, 14:1334126
-
Viruses, 2024, 16(3)323
|
|
S2579 |
Zidovudine
|
Zidovudine (ZDV, Azidothymidine, NSC 602670) is a nucleoside analogue reverse transcriptase inhibitor, used to treat HIV. |
-
Nat Commun, 2024, 15(1):2716
-
Angiogenesis, 2024, 10.1007/s10456-024-09949-1
-
bioRxiv, 2024, 10.1101/2024.01.22.576652
|
|
S1706 |
Lamivudine
|
Lamivudine is a potent nucleoside analog reverse transcriptase inhibitor, used for treatment of chronic HBV and HIV/AIDS. It works by blocking the HIV reverse transcriptase and hepatitis B virus polymerase. |
-
J Biomed Sci, 2024, 31(1):34
-
Sci Rep, 2024, 14(1):9167
-
Sci Rep, 2024, 14(1):9167
|
|
S7303 |
Rilpivirine
|
Rilpivirine (R278474, TMC27, DB08864) is a non-nucleoside reverse transcriptase inhibitor (NNRTI), and used to treat HIV-1 infection. |
-
Nat Chem Biol, 2023, 19(4):431-439
-
Antimicrob Agents Chemother, 2023, 67(7):e0046223
-
J Virol, 2022, JVI0173021
|
|
S1704 |
Emtricitabine (FTC)
|
Emtricitabine (FTC) is a new nucleoside agent that has activity against both human immunodeficiency virus (HIV) and hepatitis B virus. It is a reverse transcriptase inhibitor. Intracellular half-life is 39 h. |
-
J Biomed Sci, 2024, 31(1):34
-
Clin Immunol, 2024, 260:109915
-
Sci Rep, 2024, 14(1):9167
|
|
S5246 |
Entecavir
|
Entecavir(BMS200475,SQ34676), a new deoxyguanine nucleoside analogue, is a selective inhibitor of the replication of the hepatitis B virus (HBV). |
-
J Biomed Sci, 2024, 31(1):34
-
NPJ Vaccines, 2024, 9(1):22
-
Viruses, 2024, 16(3)323
|
|
S4685 |
Efavirenz
|
Efavirenz is a synthetic non-nucleoside reverse transcriptase (RT) inhibitor with antiviral activity. |
-
Front Cell Infect Microbiol, 2024, 14:1334126
-
Nat Chem Biol, 2023, 19(4):431-439
-
Antimicrob Agents Chemother, 2023, 67(7):e0046223
|
|
S2914 |
Dapivirine (TMC120)
|
Dapivirine (TMC120) is a non-nucleoside inhibitor for HIV reverse transcriptase with IC50 of 24 nM, inhibits a broad panel of HIV-1 isolates from different classes, inclucing a wide range of NNRTI-resistant isolates. Phase 3. |
-
Pharmaceutics, 2022, 14(9)1938
-
Viruses, 2022, 14(8)1723
-
PLoS Pathog, 2020, 16(12):e1009024
|
|
S1252 |
Entecavir Hydrate
|
Entecavir Hydrate (ETV, Baraclude,BMS200475 Hydrate,SQ34676 Hydrate), a new deoxyguanine nucleoside analogue, is a selective inhibitor of the replication of the hepatitis B virus (HBV). |
-
Cancer Discov, 2022, candisc.1117.2021
-
Hepatology, 2022, 10.1002/hep.32614
-
Cell Rep, 2022, 39(10):110913
|
|
S1742 |
Nevirapine (NSC 641530)
|
Nevirapine (NSC 641530,NVP) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used to treat HIV-1 infection and AIDS. |
-
Antimicrob Agents Chemother, 2023, 67(7):e0046223
-
Cell Rep Methods, 2023, 3(4):100443
-
J Virol, 2022, JVI0173021
|
|
S5215 |
Abacavir
|
Abacavir is a powerful nucleoside analog reverse transcriptase inhibitor (NRTI) used to treat HIV and AIDS. |
-
Antimicrob Agents Chemother, 2023, 67(7):e0046223
-
Cancer Discov, 2022, candisc.1117.2021
-
J Virol, 2021, JVI.02305-20
|
|
S7856 |
Tenofovir Alafenamide
|
Tenofovir Alafenamide is a prodrug of tenofovir, which is a reverse transcriptase inhibitor, used to treat HIV and Hepatitis B.
|
-
Hepatol Commun, 2024, 8(1)e0351
-
Int J Mol Sci, 2022, 23(23)15380
-
Antiviral Res, 2021, 197:105211
|
|
S3080 |
Etravirine
|
Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used for the treatment of HIV. |
-
Antimicrob Agents Chemother, 2023, 67(7):e0046223
-
Front Cell Dev Biol, 2019, 7:204
-
J Virol, 2019, 93(9)
|
|
S1398 |
Stavudine (d4T)
|
Stavudine (d4T, BMY-27857, Sanilvudine, NSC 163661) is a nucleoside analog reverse transcriptase inhibitor (NARTI) active against HIV. |
-
Nat Commun, 2024, 15(1):2716
-
bioRxiv, 2024, 10.1101/2024.01.22.576652
-
Antiviral Res, 2023, 216:105674
|
|
S1719 |
Zalcitabine
|
Zalcitabine (NSC 606170, Ro 24-2027/000) is a nucleoside analog HIV reverse transcriptase inhibitor (NARTI). |
-
Sci Rep, 2024, 14(1):9167
-
Sci Rep, 2024, 14(1):9167
-
Cancer Discov, 2022, candisc.1117.2021
|
|
S3165 |
Abacavir sulfate
|
Abacavir (1592U89) is a commonly used nucleoside analogue with potent antiviral activity against HIV-1. |
-
Cell, 2023, 186(2):287-304.e26
-
Cell Rep, 2023, 42(6):112593
-
Cancer Discov, 2022, candisc.1117.2021
|
|
S1718 |
Adefovir Dipivoxil (GS 0840)
|
Adefovir Dipivoxil (GS 0840) is a reverse transcriptase inhibitor, used in the treatment of chronic hepatitis B virus (HBV). |
-
Biomedicines, 2021, 9(8)996
-
Front Immunol, 2020, 11:616570
-
Oncol Lett, 2018, 15(5):6107-6114
|
|
S1702 |
Didanosine
|
Didanosine is a reverse transcriptase inhibitor with an IC50 of 0.49 μM. |
-
Antimicrob Agents Chemother, 2023, 67(7):e0046223
-
Cancer Res Commun, 2023, 3(10):2030-2043
-
Environ Mol Mutagen, 2022, 3(7):329-335.
|
|
S1651 |
Telbivudine
|
Telbivudine(NV 02B) is a potent, and selective HBV reverse transcriptase inhibitor, used to treat HBV infection. |
-
Biomedicines, 2021, 9(8)996
-
Oncotarget, 2017, 8(15):24694-24705
-
Sci Rep, 2013, 3:2105
|
|
S3076 |
Foscarnet Sodium
|
Foscarnet Sodium (Phosphonoformate) inhibits viral RNA polymerases, reverse transcriptase, and DNA polymerases through noncompetitive inhibition with dNTPs. |
-
Front Cell Infect Microbiol, 2020, 10:536150
-
Neuron, 2017, 96(6):1290-1302
|
|
S4879 |
Tenofovir hydrate
|
Tenofovir (GS-1278) hydrate blocks reverse transcriptase and hepatitis B virus infections. |
-
Cancer Discov, 2022, candisc.1117.2021
-
Cells, 2020, 9(4)E1003
|
|
S5959 |
Tenofovir Disoproxil
|
Tenofovir Disoproxil (Bis(POC)-PMPA, GS 4331) is a prodrug of tenofovir, which is metabolised intracellularly to its active anabolite tenofovir diphosphate, a competitive inhibitor of HIV-1 reverse transcriptase and terminates the growing DNA chain. |
-
J Virol, 2022, JVI0173021
-
Front Microbiol, 2018, 9:278
|
|
S4428 |
Tenofovir alafenamide fumarate
|
Tenofovir alafenamide (TAF, GS-7340) fumarate is a prodrug of tenofovir but results in significantly higher intracellular tenofovir concentrations and lower serum levels. Tenofovir alafenamide is a novel nucleotide reverse transcriptase inhibitor for the treatment of HIV-1 infection. |
-
Cells, 2021, 10(9)2321
-
Front Microbiol, 2018, 9:278
|
|
S4187 |
Salicylanilide
|
Salicylanilides (WR10019,2-Hydroxybenzanilide) are a group of compounds with a wide range of biological activities including antiviral potency, antibacterial (including antimycobacterial) and antifungal activities. |
-
Hum Mol Genet, 2020, ddaa244
|
|
S3606 |
Fangchinoline
|
Fangchinoline, a bisbenzylisoquinoline alkaloid, is a novel HIV-1 inhibitor with pain-relieving, blood pressure-depressing, and antibiotic activities.
|
-
Pathogens, 2023, 12(6)845
-
Pathogens, 2023, 12(6)845
|
|
S6452 |
Delavirdine mesylate
|
Delavirdine Mesylate(U 90152 mesylate) is a mesylate salt form of delavirdine, which is a synthetic, non-nucleoside reverse transcriptase inhibitor. |
-
J Cheminform, 2021, 13(1):90
|
|
S4427 |
Tenofovir alafenamide hemifumarate
|
Tenofovir alafenamide (TAF, GS-7340) hemifumarate is a prodrug of tenofovir but results in significantly higher intracellular tenofovir concentrations and lower serum levels. Tenofovir alafenamide is a novel nucleotide reverse transcriptase inhibitor for the treatment of HIV-1 infection. |
-
Front Microbiol, 2018, 9:278
|
|
S6492 |
Doravirine
|
Doravirine is a novel HIV-1 nonnucleoside reverse transcriptase inhibitor with IC50 values of 12, 9.7, and 9.7 nM against the wild type (WT) and K103N and Y181C reverse transcriptase (RT) mutants, respectively, in a biochemical assay. It is highly specific with minimum off-target activities. |
-
Nat Chem Biol, 2023, 19(4):431-439
|
|
S3273 |
Hypericin
|
Hypericin (Hyp, HY) is a naturally occurring substance found in the common St. John's Wort (Hypericum species) with antidepressive, antineoplastic and antiviral (human immunodeficiency and hepatitis C virus) activities. Hypericin has inhibitory effects on MAO (monoaminoxidase), PKC (protein kinase C), dopamine-beta-hydroxylase, reverse transcriptase, telomerase and CYP (cytochrome P450). |
-
Eur J Pharmacol, 2021, 900:174071
|
|
S4890 |
Bifendate
|
Bifendate, a synthetic intermediate of schisandrin C, is an anti-HBV drug used in Chinese medicine for the treatment of chronic hepatitis B. |
|
|
S6848 |
3'-Fluoro-3'-deoxythymidine (Alovudine)
|
3'-Fluoro-3'-deoxythymidine (Alovudine, CL 184824, FddThd, FLT, MIV-310) is a potent inhibitor of polymerase γ and reverse transcriptase that can be used in the treatment of HIV infection. 3'-Fluoro-3'-deoxythymidine (Alovudine) is also a marker of DNA synthesis that can be used as an early response biomarker in the chemotherapy of pancreatic cancer. |
|
|
E0815 |
Rilpivirine Hydrochloride
|
Rilpivirine (TMC278), is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) with higher potency, longer half-life and reduced side-effect profile compared with older NNRTIs, such as efavirenz. |
|
|
E1745New |
Ulonivirine
|
Ulonivirine(MK-8507) is a selective and potent inhibitor of HIV-1 nonnucleoside reverse transcriptase (NNRTI) that binds to the classic NNRTI hydrophobic binding pocket near the polymerase active site. It demonstrates a potential to treat HIV-1 infections and induce the expression of CYP3A4, an enzyme often involved in drug metabolism. |
|
|
S8055 |
Lersivirine (UK-453061)
|
Lersivirine (UK-453061) is a potent and selective inhibitor of nonnucleoside reverse transcriptase (NNRTI) with IC50 of 0.119 μM. |
|
|
S5423 |
4-Chloro-2-(trifluoroacetyl)aniline hydrochloride
|
4-Chloro-2-(trifluoroacetyl)aniline hydrochloride is a HIV-1 RT (HIV reverse transcriptase) inhibitor. |
|
|
S5068 |
Adefovir
|
Adefovir is an orally administered nucleotide analog reverse transcriptase inhibitor used for treatment of hepatitis B and herpes simplex virus infection. |
-
Hepatol Commun, 2024, 8(1)e0351
|
|
S1401 |
Tenofovir
|
Tenofovir (GS-1278) blocks reverse transcriptase and hepatitis B virus infections. |
- J Biomed Sci, 2024, 31(1):34
- Hepatol Commun, 2024, 8(1)e0351
- Nat Commun, 2023, 14(1):199
|
|
S1400 |
Tenofovir Disoproxil Fumarate
|
Tenofovir Disoproxil Fumarate belongs to a class of antiretroviral drugs, it inhibits the activity of HIV reverse transcriptase by competing with the natural substrate deoxyadenosine 5’-triphosphate and, after incorporation into DNA, by DNA chain termination. |
- Clin Immunol, 2024, 260:109915
- Front Cell Infect Microbiol, 2024, 14:1334126
- Viruses, 2024, 16(3)323
|
|
S2579 |
Zidovudine
|
Zidovudine (ZDV, Azidothymidine, NSC 602670) is a nucleoside analogue reverse transcriptase inhibitor, used to treat HIV. |
- Nat Commun, 2024, 15(1):2716
- Angiogenesis, 2024, 10.1007/s10456-024-09949-1
- bioRxiv, 2024, 10.1101/2024.01.22.576652
|
|
S1706 |
Lamivudine
|
Lamivudine is a potent nucleoside analog reverse transcriptase inhibitor, used for treatment of chronic HBV and HIV/AIDS. It works by blocking the HIV reverse transcriptase and hepatitis B virus polymerase. |
- J Biomed Sci, 2024, 31(1):34
- Sci Rep, 2024, 14(1):9167
- Sci Rep, 2024, 14(1):9167
|
|
S7303 |
Rilpivirine
|
Rilpivirine (R278474, TMC27, DB08864) is a non-nucleoside reverse transcriptase inhibitor (NNRTI), and used to treat HIV-1 infection. |
- Nat Chem Biol, 2023, 19(4):431-439
- Antimicrob Agents Chemother, 2023, 67(7):e0046223
- J Virol, 2022, JVI0173021
|
|
S1704 |
Emtricitabine (FTC)
|
Emtricitabine (FTC) is a new nucleoside agent that has activity against both human immunodeficiency virus (HIV) and hepatitis B virus. It is a reverse transcriptase inhibitor. Intracellular half-life is 39 h. |
- J Biomed Sci, 2024, 31(1):34
- Clin Immunol, 2024, 260:109915
- Sci Rep, 2024, 14(1):9167
|
|
S5246 |
Entecavir
|
Entecavir(BMS200475,SQ34676), a new deoxyguanine nucleoside analogue, is a selective inhibitor of the replication of the hepatitis B virus (HBV). |
- J Biomed Sci, 2024, 31(1):34
- NPJ Vaccines, 2024, 9(1):22
- Viruses, 2024, 16(3)323
|
|
S4685 |
Efavirenz
|
Efavirenz is a synthetic non-nucleoside reverse transcriptase (RT) inhibitor with antiviral activity. |
- Front Cell Infect Microbiol, 2024, 14:1334126
- Nat Chem Biol, 2023, 19(4):431-439
- Antimicrob Agents Chemother, 2023, 67(7):e0046223
|
|
S2914 |
Dapivirine (TMC120)
|
Dapivirine (TMC120) is a non-nucleoside inhibitor for HIV reverse transcriptase with IC50 of 24 nM, inhibits a broad panel of HIV-1 isolates from different classes, inclucing a wide range of NNRTI-resistant isolates. Phase 3. |
- Pharmaceutics, 2022, 14(9)1938
- Viruses, 2022, 14(8)1723
- PLoS Pathog, 2020, 16(12):e1009024
|
|
S1252 |
Entecavir Hydrate
|
Entecavir Hydrate (ETV, Baraclude,BMS200475 Hydrate,SQ34676 Hydrate), a new deoxyguanine nucleoside analogue, is a selective inhibitor of the replication of the hepatitis B virus (HBV). |
- Cancer Discov, 2022, candisc.1117.2021
- Hepatology, 2022, 10.1002/hep.32614
- Cell Rep, 2022, 39(10):110913
|
|
S1742 |
Nevirapine (NSC 641530)
|
Nevirapine (NSC 641530,NVP) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used to treat HIV-1 infection and AIDS. |
- Antimicrob Agents Chemother, 2023, 67(7):e0046223
- Cell Rep Methods, 2023, 3(4):100443
- J Virol, 2022, JVI0173021
|
|
S5215 |
Abacavir
|
Abacavir is a powerful nucleoside analog reverse transcriptase inhibitor (NRTI) used to treat HIV and AIDS. |
- Antimicrob Agents Chemother, 2023, 67(7):e0046223
- Cancer Discov, 2022, candisc.1117.2021
- J Virol, 2021, JVI.02305-20
|
|
S7856 |
Tenofovir Alafenamide
|
Tenofovir Alafenamide is a prodrug of tenofovir, which is a reverse transcriptase inhibitor, used to treat HIV and Hepatitis B.
|
- Hepatol Commun, 2024, 8(1)e0351
- Int J Mol Sci, 2022, 23(23)15380
- Antiviral Res, 2021, 197:105211
|
|
S3080 |
Etravirine
|
Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used for the treatment of HIV. |
- Antimicrob Agents Chemother, 2023, 67(7):e0046223
- Front Cell Dev Biol, 2019, 7:204
- J Virol, 2019, 93(9)
|
|
S1398 |
Stavudine (d4T)
|
Stavudine (d4T, BMY-27857, Sanilvudine, NSC 163661) is a nucleoside analog reverse transcriptase inhibitor (NARTI) active against HIV. |
- Nat Commun, 2024, 15(1):2716
- bioRxiv, 2024, 10.1101/2024.01.22.576652
- Antiviral Res, 2023, 216:105674
|
|
S1719 |
Zalcitabine
|
Zalcitabine (NSC 606170, Ro 24-2027/000) is a nucleoside analog HIV reverse transcriptase inhibitor (NARTI). |
- Sci Rep, 2024, 14(1):9167
- Sci Rep, 2024, 14(1):9167
- Cancer Discov, 2022, candisc.1117.2021
|
|
S3165 |
Abacavir sulfate
|
Abacavir (1592U89) is a commonly used nucleoside analogue with potent antiviral activity against HIV-1. |
- Cell, 2023, 186(2):287-304.e26
- Cell Rep, 2023, 42(6):112593
- Cancer Discov, 2022, candisc.1117.2021
|
|
S1718 |
Adefovir Dipivoxil (GS 0840)
|
Adefovir Dipivoxil (GS 0840) is a reverse transcriptase inhibitor, used in the treatment of chronic hepatitis B virus (HBV). |
- Biomedicines, 2021, 9(8)996
- Front Immunol, 2020, 11:616570
- Oncol Lett, 2018, 15(5):6107-6114
|
|
S1702 |
Didanosine
|
Didanosine is a reverse transcriptase inhibitor with an IC50 of 0.49 μM. |
- Antimicrob Agents Chemother, 2023, 67(7):e0046223
- Cancer Res Commun, 2023, 3(10):2030-2043
- Environ Mol Mutagen, 2022, 3(7):329-335.
|
|
S1651 |
Telbivudine
|
Telbivudine(NV 02B) is a potent, and selective HBV reverse transcriptase inhibitor, used to treat HBV infection. |
- Biomedicines, 2021, 9(8)996
- Oncotarget, 2017, 8(15):24694-24705
- Sci Rep, 2013, 3:2105
|
|
S3076 |
Foscarnet Sodium
|
Foscarnet Sodium (Phosphonoformate) inhibits viral RNA polymerases, reverse transcriptase, and DNA polymerases through noncompetitive inhibition with dNTPs. |
- Front Cell Infect Microbiol, 2020, 10:536150
- Neuron, 2017, 96(6):1290-1302
|
|
S4879 |
Tenofovir hydrate
|
Tenofovir (GS-1278) hydrate blocks reverse transcriptase and hepatitis B virus infections. |
- Cancer Discov, 2022, candisc.1117.2021
- Cells, 2020, 9(4)E1003
|
|
S5959 |
Tenofovir Disoproxil
|
Tenofovir Disoproxil (Bis(POC)-PMPA, GS 4331) is a prodrug of tenofovir, which is metabolised intracellularly to its active anabolite tenofovir diphosphate, a competitive inhibitor of HIV-1 reverse transcriptase and terminates the growing DNA chain. |
- J Virol, 2022, JVI0173021
- Front Microbiol, 2018, 9:278
|
|
S4428 |
Tenofovir alafenamide fumarate
|
Tenofovir alafenamide (TAF, GS-7340) fumarate is a prodrug of tenofovir but results in significantly higher intracellular tenofovir concentrations and lower serum levels. Tenofovir alafenamide is a novel nucleotide reverse transcriptase inhibitor for the treatment of HIV-1 infection. |
- Cells, 2021, 10(9)2321
- Front Microbiol, 2018, 9:278
|
|
S4187 |
Salicylanilide
|
Salicylanilides (WR10019,2-Hydroxybenzanilide) are a group of compounds with a wide range of biological activities including antiviral potency, antibacterial (including antimycobacterial) and antifungal activities. |
- Hum Mol Genet, 2020, ddaa244
|
|
S3606 |
Fangchinoline
|
Fangchinoline, a bisbenzylisoquinoline alkaloid, is a novel HIV-1 inhibitor with pain-relieving, blood pressure-depressing, and antibiotic activities.
|
- Pathogens, 2023, 12(6)845
- Pathogens, 2023, 12(6)845
|
|
S6452 |
Delavirdine mesylate
|
Delavirdine Mesylate(U 90152 mesylate) is a mesylate salt form of delavirdine, which is a synthetic, non-nucleoside reverse transcriptase inhibitor. |
- J Cheminform, 2021, 13(1):90
|
|
S4427 |
Tenofovir alafenamide hemifumarate
|
Tenofovir alafenamide (TAF, GS-7340) hemifumarate is a prodrug of tenofovir but results in significantly higher intracellular tenofovir concentrations and lower serum levels. Tenofovir alafenamide is a novel nucleotide reverse transcriptase inhibitor for the treatment of HIV-1 infection. |
- Front Microbiol, 2018, 9:278
|
|
S6492 |
Doravirine
|
Doravirine is a novel HIV-1 nonnucleoside reverse transcriptase inhibitor with IC50 values of 12, 9.7, and 9.7 nM against the wild type (WT) and K103N and Y181C reverse transcriptase (RT) mutants, respectively, in a biochemical assay. It is highly specific with minimum off-target activities. |
- Nat Chem Biol, 2023, 19(4):431-439
|
|
S3273 |
Hypericin
|
Hypericin (Hyp, HY) is a naturally occurring substance found in the common St. John's Wort (Hypericum species) with antidepressive, antineoplastic and antiviral (human immunodeficiency and hepatitis C virus) activities. Hypericin has inhibitory effects on MAO (monoaminoxidase), PKC (protein kinase C), dopamine-beta-hydroxylase, reverse transcriptase, telomerase and CYP (cytochrome P450). |
- Eur J Pharmacol, 2021, 900:174071
|
|
S4890 |
Bifendate
|
Bifendate, a synthetic intermediate of schisandrin C, is an anti-HBV drug used in Chinese medicine for the treatment of chronic hepatitis B. |
|
|
S6848 |
3'-Fluoro-3'-deoxythymidine (Alovudine)
|
3'-Fluoro-3'-deoxythymidine (Alovudine, CL 184824, FddThd, FLT, MIV-310) is a potent inhibitor of polymerase γ and reverse transcriptase that can be used in the treatment of HIV infection. 3'-Fluoro-3'-deoxythymidine (Alovudine) is also a marker of DNA synthesis that can be used as an early response biomarker in the chemotherapy of pancreatic cancer. |
|
|
E0815 |
Rilpivirine Hydrochloride
|
Rilpivirine (TMC278), is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) with higher potency, longer half-life and reduced side-effect profile compared with older NNRTIs, such as efavirenz. |
|
|
E1745New |
Ulonivirine
|
Ulonivirine(MK-8507) is a selective and potent inhibitor of HIV-1 nonnucleoside reverse transcriptase (NNRTI) that binds to the classic NNRTI hydrophobic binding pocket near the polymerase active site. It demonstrates a potential to treat HIV-1 infections and induce the expression of CYP3A4, an enzyme often involved in drug metabolism. |
|
|
S8055 |
Lersivirine (UK-453061)
|
Lersivirine (UK-453061) is a potent and selective inhibitor of nonnucleoside reverse transcriptase (NNRTI) with IC50 of 0.119 μM. |
|
|
S5423 |
4-Chloro-2-(trifluoroacetyl)aniline hydrochloride
|
4-Chloro-2-(trifluoroacetyl)aniline hydrochloride is a HIV-1 RT (HIV reverse transcriptase) inhibitor. |
|
|
S5068 |
Adefovir
|
Adefovir is an orally administered nucleotide analog reverse transcriptase inhibitor used for treatment of hepatitis B and herpes simplex virus infection. |
- Hepatol Commun, 2024, 8(1)e0351
|
|